In a recurrent tumor in the parapharyngeal space of the patient discussed in our report, ARID1A G2087R, PRKR1A F200fs∗6, and RAD21 amplification were identified as disease-relevant alterations by genetic testing. Here, RAD21 is linked to neoplasm.